Annual FCF
-$117.28 M
-$20.89 M-21.67%
December 31, 2023
Summary
- As of February 7, 2025, PLRX annual free cash flow is -$117.28 million, with the most recent change of -$20.89 million (-21.67%) on December 31, 2023.
- During the last 3 years, PLRX annual FCF has fallen by -$78.48 million (-202.25%).
- PLRX annual FCF is now -3057.84% below its all-time high of -$3.71 million, reached on December 31, 2019.
Performance
PLRX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$33.17 M
+$13.38 M+28.74%
September 30, 2024
Summary
- As of February 7, 2025, PLRX quarterly free cash flow is -$33.17 million, with the most recent change of +$13.38 million (+28.74%) on September 30, 2024.
- Over the past year, PLRX quarterly FCF has increased by +$13.38 million (+28.74%).
- PLRX quarterly FCF is now -190.72% below its all-time high of $36.56 million, reached on December 31, 2019.
Performance
PLRX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$136.64 M
+$3.15 M+2.25%
September 30, 2024
Summary
- As of February 7, 2025, PLRX TTM free cash flow is -$136.64 million, with the most recent change of +$3.15 million (+2.25%) on September 30, 2024.
- Over the past year, PLRX TTM FCF has increased by +$3.15 million (+2.25%).
- PLRX TTM FCF is now -952.95% below its all-time high of $16.02 million, reached on June 30, 2020.
Performance
PLRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
PLRX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.7% | +28.7% | +2.3% |
| 3 y3 years | -202.3% | +28.7% | +2.3% |
| 5 y5 years | -282.6% | -190.7% | -3579.1% |
PLRX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -51.5% | at low | -72.8% | +28.7% | -76.5% | +2.3% |
| 5 y | 5-year | -3057.8% | at low | -190.7% | +28.7% | -953.0% | +2.3% |
| alltime | all time | -3057.8% | at low | -190.7% | +28.7% | -953.0% | +2.3% |
Pliant Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$33.17 M(-28.7%) | -$136.64 M(-2.3%) |
| Jun 2024 | - | -$46.55 M(+46.5%) | -$139.79 M(+17.9%) |
| Mar 2024 | - | -$31.76 M(+26.2%) | -$118.61 M(+1.1%) |
| Dec 2023 | -$117.28 M(+21.7%) | -$25.16 M(-30.7%) | -$117.28 M(-5.1%) |
| Sep 2023 | - | -$36.32 M(+43.2%) | -$123.52 M(+16.1%) |
| Jun 2023 | - | -$25.36 M(-16.7%) | -$106.40 M(+0.7%) |
| Mar 2023 | - | -$30.44 M(-3.1%) | -$105.69 M(+9.6%) |
| Dec 2022 | -$96.39 M(+24.5%) | -$31.41 M(+63.6%) | -$96.39 M(+12.8%) |
| Sep 2022 | - | -$19.19 M(-22.1%) | -$85.44 M(-4.3%) |
| Jun 2022 | - | -$24.65 M(+16.6%) | -$89.24 M(+5.4%) |
| Mar 2022 | - | -$21.14 M(+3.3%) | -$84.63 M(+9.3%) |
| Dec 2021 | -$77.40 M | -$20.46 M(-11.0%) | -$77.40 M(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$22.99 M(+14.7%) | -$74.01 M(+10.2%) |
| Jun 2021 | - | -$20.04 M(+44.1%) | -$67.14 M(+69.5%) |
| Mar 2021 | - | -$13.91 M(-18.5%) | -$39.61 M(+2.1%) |
| Dec 2020 | -$38.80 M(+944.8%) | -$17.07 M(+5.9%) | -$38.80 M(-361.7%) |
| Sep 2020 | - | -$16.11 M(-315.3%) | $14.83 M(-7.4%) |
| Jun 2020 | - | $7.49 M(-157.1%) | $16.02 M(-380.5%) |
| Mar 2020 | - | -$13.10 M(-135.8%) | -$5.71 M(+53.8%) |
| Dec 2019 | -$3.71 M(-87.9%) | $36.56 M(-345.0%) | -$3.71 M(-90.8%) |
| Sep 2019 | - | -$14.92 M(+4.8%) | -$40.27 M(+58.9%) |
| Jun 2019 | - | -$14.24 M(+28.3%) | -$25.35 M(+128.3%) |
| Mar 2019 | - | -$11.11 M | -$11.11 M |
| Dec 2018 | -$30.65 M | - | - |
FAQ
- What is Pliant Therapeutics annual free cash flow?
- What is the all time high annual FCF for Pliant Therapeutics?
- What is Pliant Therapeutics annual FCF year-on-year change?
- What is Pliant Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Pliant Therapeutics?
- What is Pliant Therapeutics quarterly FCF year-on-year change?
- What is Pliant Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Pliant Therapeutics?
- What is Pliant Therapeutics TTM FCF year-on-year change?
What is Pliant Therapeutics annual free cash flow?
The current annual FCF of PLRX is -$117.28 M
What is the all time high annual FCF for Pliant Therapeutics?
Pliant Therapeutics all-time high annual free cash flow is -$3.71 M
What is Pliant Therapeutics annual FCF year-on-year change?
Over the past year, PLRX annual free cash flow has changed by -$20.89 M (-21.67%)
What is Pliant Therapeutics quarterly free cash flow?
The current quarterly FCF of PLRX is -$33.17 M
What is the all time high quarterly FCF for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly free cash flow is $36.56 M
What is Pliant Therapeutics quarterly FCF year-on-year change?
Over the past year, PLRX quarterly free cash flow has changed by +$13.38 M (+28.74%)
What is Pliant Therapeutics TTM free cash flow?
The current TTM FCF of PLRX is -$136.64 M
What is the all time high TTM FCF for Pliant Therapeutics?
Pliant Therapeutics all-time high TTM free cash flow is $16.02 M
What is Pliant Therapeutics TTM FCF year-on-year change?
Over the past year, PLRX TTM free cash flow has changed by +$3.15 M (+2.25%)